eriodictyol has been researched along with Breast Neoplasms in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Boumendjel, A; Ehrlichová, M; Gut, I; Kondrová, E; Kovár, J; Soucek, P; Stopka, P; Václavíková, R | 1 |
Chang, H; Deng, Z; Fu, H; He, J; Li, C | 1 |
Cen, YZ; Fan, ZY; Guo, GQ; Jiang, ZY; Li, YL; She, WZ; Wang, H | 1 |
3 other study(ies) available for eriodictyol and Breast Neoplasms
Article | Year |
---|---|
The effect of flavonoid derivatives on doxorubicin transport and metabolism.
Topics: Antibiotics, Antineoplastic; Benzofurans; Biological Transport; Breast Neoplasms; Cell Line, Tumor; Doxorubicin; Female; Flavonoids; Humans; Metabolism; Quercetin | 2008 |
Eriodictyol inhibits breast carcinogenesis by targeting circ_0007503 and repressing PI3K/Akt pathway.
Topics: Animals; Breast Neoplasms; Carcinogens, Environmental; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Female; Flavanones; Humans; MicroRNAs; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction | 2022 |
[Studies on antiproliferative effect of flavones compounds isolated from Yao herb medicines].
Topics: Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Chlorocebus aethiops; Dose-Response Relationship, Drug; Female; Flavanones; Flavones; Humans; Liver Neoplasms; Melanocytes; Molecular Structure; Plants, Medicinal; Quercetin; Vero Cells | 2007 |